Looking for RET alterations in thyroid cancer: clinical relevance, methodology and timing
- 17 May 2023
- journal article
- review article
- Published by Springer Nature in Endocrine
- Vol. 81 (2) , 206-215
Abstract
Purpose Thyroid carcinoma (TC) is a rare neoplasia of the endocrine system and account for about 2–3% of all human tumors. According to their cell origin and histological features, different histotypes of thyroid carcinoma are described. Genetic alterations involved in the pathogenesis of thyroid cancer have been described and it has been shown that alterations of the RET gene are common events in all TC hystotypes. Aim of this review is to give an overview of the relevance of RET alterations in TC and to provide indications, timing and methodologies, for RET genetic analysis. Methods A revision of the literature has been performed and indications for the experimental approach for the RET analysis have been reported. Conclusions The analysis of RET mutations in TC has a very important clinical relevance for the early diagnosis of the hereditary forms of MTC, for the follow-up of TC patients and for the identification of those cases that can benefit from a specific treatment able to inhibit the effect of mutated RET.Keywords
This publication has 70 references indexed in Scilit:
- Genetic and Clinical Features of Multiple Endocrine Neoplasia Types 1 and 2Journal of Oncology, 2012
- Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III TrialJournal of Clinical Oncology, 2012
- Predicting Phenotypic Severity of Uncertain Gene Variants in the RET Proto-OncogenePLOS ONE, 2011
- RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)Clinical Endocrinology, 2011
- Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomasBritish Journal of Cancer, 2009
- Rising Thyroid Cancer Incidence in the United States by Demographic and Tumor Characteristics, 1980-2005Cancer Epidemiology, Biomarkers & Prevention, 2009
- RET tyrosine kinase signaling in development and cancerCytokine & Growth Factor Reviews, 2005
- Solid Variant of Papillary Thyroid CarcinomaAmerican Journal of Surgical Pathology, 2001
- Papillary and Follicular Thyroid CarcinomaNew England Journal of Medicine, 1998
- Medullary Thyroid Carcinoma: Clinicopathologic Features and Long-Term Follow-Up of 65 Patients Treated During 1946 Through 1970Mayo Clinic Proceedings, 1992